The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
Open accessAbstract
The Hippo signaling pathway plays a crucial role in tissue growth and tumorigenesis. Core components of the Hippo pathway include the MST1/2 and Lats1/2 kinases. Acting downstream from the Hippo pathway are the YAP/TAZ transcription coactivators, which are inhibited through phosphorylation by Lats. However, upstream signals that regulate the Hippo pathway have not been well delineated. Here we report that stimulation of protease-activated receptors (PARs) activates YAP/TAZ by decreasing phosphorylation and increasing nuclear localization. PAR1 acts through G 12/13 and Rho GTPase to inhibit the Lats1/2 kinase. Our observations establish thrombin as a physiological signal for the Hippo pathway and implicate Hippo–YAP as a key downstream signaling branch of PAR activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationThrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Self-citationThe Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
Self-citationProteinase-activated Receptors
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Lei, Q.-Y., Zhang, H., Zhao, B., Zha, Z.-Y., Bai, F., Pei, X.-H., Zhao, S., Xiong, Y., & Guan, K.-L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 924
Self-citationTransforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
Hippo pathway regulation by cell morphology and stress fibers
Wada, K.-I., Itoga, K., Okano, T., Yonemura, S., & Sasaki, H. (2011) · Development · doi:10.1242/dev.070987 · Cited by 849
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Zhao, B., Li, L., Wang, L., Wang, C.-Y., Yu, J., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.173435.111 · Cited by 793
Self-citationProteinase-Activated Receptors
Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D., & Plevin, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01493-5 · Cited by 641
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., & Hong, W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2696 · Cited by 478
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
Sansores‐Garcia, L., Bossuyt, W., Wada, K., Yonemura, S., Tao, C., Sasaki, H., & Halder, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.157 · Cited by 430
Thrombin receptor overexpression in malignant and physiological invasion processes
Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., & Bar-Shavit, R. (1998) · Nature Medicine · doi:10.1038/nm0898-909 · Cited by 417
Targeting proteinase-activated receptors: therapeutic potential and challenges
Ramachandran, R., Noorbakhsh, F., DeFea, K., & Hollenberg, M. D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3615 · Cited by 312
Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila
Fernández, B. G., Gaspar, P., Brás-Pereira, C., Jezowska, B., Rebelo, S. R., & Janody, F. (2011) · Development · doi:10.1242/dev.063545 · Cited by 293
Zhang, J., Smolen, G. A., & Haber, D. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6205 · Cited by 243
Vouret-Craviari, V., Boquet, P., Pouysségur, J., & Van Obberghen-Schilling, E. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.9.2639 · Cited by 240
Chambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E., & Laurent, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003188200 · Cited by 233
Upstream Regulation of the Hippo Size Control Pathway
Grusche, F. A., Richardson, H. E., & Harvey, K. F. (2010) · Current Biology · doi:10.1016/j.cub.2010.05.023 · Cited by 196
McLaughlin, J. N., Shen, L., Holinstat, M., Brooks, J. D., DiBenedetto, E., & Hamm, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414090200 · Cited by 186
Zyxin Links Fat Signaling to the Hippo Pathway
Rauskolb, C., Pan, G., Reddy, B. V. V. G., Oh, H., & Irvine, K. D. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000624 · Cited by 176
Pendurthi, U. R., Allen, K. E., Ezban, M., & Rao, L. V. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14632 · Cited by 145
Role and regulation of the thrombin receptor (PAR-1) in human melanoma
Tellez, C. S., & Bar‐Eli, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206453 · Cited by 129
Booden, M. A., Eckert, L. B., Der, C. J., & Trejo, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.1990-1999.2004 · Cited by 120
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways
Martin, C. B., Mahon, G. M., Klinger, M., Kay, R. J., Symons, M. H., Der, C. J., & Whitehead, I. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204281 · Cited by 115
Pendurthi, U. R., Ngyuen, M., Andrade‐Gordon, P., Petersen, L. C., & Rao, L. V. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000030200.59331.3f · Cited by 91
Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer
Elste, A. P., & Petersen, I. (2010) · Journal of Molecular Histology · doi:10.1007/s10735-010-9274-6 · Cited by 65
Offermanns, S., Jones, S. V. P., Bombien, E., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.250 · Cited by 61
Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine‐rich protein 61
Walsh, C. T., Radeff‐Huang, J., Matteo, R., Hsiao, A., Subramaniam, S., Stupack, D., & Brown, J. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-113266 · Cited by 47
Self-citationPAR1 plays a role in epithelial malignancies: Transcriptional regulation and novel signaling pathway
Bar‐Shavit, R., Turm, H., Salah, Z., Maoz, M., Cohen, I., Weiss, E., Uziely, B., & Grisaru‐Granovsky, S. (2011) · IUBMB Life · doi:10.1002/iub.452 · Cited by 29
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Self-citationThe Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
“Furthermore, energy stress-activated AMPK directly phosphorylates YAP at multiple sites, and this phosphorylation interferes with the interaction between YAP and TEAD, thus inhibiting TEAD-mediated gene transcription (Mo et al. 2015; Wang et al. 2015).”
Self-citationThe Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
Self-citation
Metadata
- Authors
- Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H., & Guan, K.-L.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-09-12
- Volume
- 26
- Issue
- 19
- Pages
- 2138-2143
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2036358056
- Cited by
- 282
- References
- 39
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.